This article is a framework for scenario analysis, not a verified transaction dataset or a report of current market averages. Behavioral health businesses cannot be valued responsibly from a published multiple table alone. Any conclusion requires normalized financials, current comparable evidence, risk analysis, and transaction-specific terms.
What Is an EBITDA Multiple?
An EBITDA multiple is one way to express enterprise value relative to adjusted earnings. EBITDA is not cash proceeds and is not defined identically in every deal. Proposed adjustments must be supported, and enterprise value must still be reconciled to debt, cash, working capital, taxes, transaction costs, escrows, earnouts, and other terms.
Illustrative Internal Scenario Table: Behavioral Health by Sub-Vertical
The table below is hypothetical internal scenario math. It contains no observed transaction ranges, market averages, hard thresholds, or pricing promises. Replace every symbol with practice-specific inputs supported by current evidence before using it in a valuation.
| Scenario | Normalized EBITDA assumption | Multiple assumption | Illustrative enterprise value |
|---|---|---|---|
| Downside case | E₁ | M₁ | E₁ × M₁ |
| Base case | E₂ | M₂ | E₂ × M₂ |
| Upside case | E₃ | M₃ | E₃ × M₃ |
These labels describe assumptions, not probability or expected value. A sensitivity table is useful only when the reader can see what evidence supports each input and what facts could invalidate it.
Why Multiples Vary Within the Same Sub-Vertical
Two practices in the same field may differ in normalized earnings, provider dependence, payer and referral concentration, clinical leadership, compliance history, facilities, documentation, growth durability, geography, and deal structure. Those differences can matter more than the sub-vertical label.
ABA Therapy Scenarios: Test the Operating Evidence
For an ABA scenario, test clinician retention, supervision capacity, owner dependence, authorization quality, payer contracts, denial and collection trends, documentation, referral flow, staffed capacity, and the source of growth. Do not assume a platform premium or current buyer dominance.
Mental Health Practice Scenarios: Test Transferability
For a mental health practice, test provider retention, owner caseload, referral durability, panel and contract requirements, appointment capacity, compensation, records stewardship, and continuity of care. Revenue size alone does not select the valuation method or buyer.
Addiction Treatment Scenarios: Test Census and Regulatory Facts
For an addiction treatment organization, test census by level of care, staffed capacity, referrals, payer contracts, licensure, accreditation where applicable, facilities, medical infrastructure, and compliance. Avoid assumed accreditation premiums, occupancy benchmarks, or generalized Medicaid economics.
Outpatient Behavioral Health: Separate the Service Lines
Mixed-service organizations should be analyzed by service line. Revenue quality, staffing, supervision, payer requirements, facilities, and risk may differ across psychiatry, therapy, intensive outpatient, testing, or other services. A blended headline can hide those differences.
How Transaction Size May Affect Buyer Fit
Scale can influence financing, buyer fit, reporting expectations, and management requirements, but it does not create an automatic size premium. The valuation still depends on earnings quality, transferability, risk, and evidence from relevant transactions.
What Scenario Multiples Mean in Dollar Terms
Illustrative enterprise value equals the selected normalized EBITDA assumption multiplied by the selected multiple assumption. That arithmetic is not a forecast. It does not determine purchase price allocation or seller proceeds and should be accompanied by a bridge showing the other economic terms.
Planning Conditions to Test in 2026
Do not rely on broad claims about private-equity activity, dry powder, interest rates, recession resistance, waiver counts, or current demand unless supported by dated primary evidence that is directly relevant to the practice. A live valuation should state the evidence used and the date it was checked.
Frequently Asked Questions: Behavioral Health EBITDA Multiples
What EBITDA multiple should I expect for my behavioral health practice?
No universal multiple can be supported across behavioral health. Expect a valuation to explain normalized earnings, risk, buyer fit, comparable evidence, and the assumptions behind any range.
Are behavioral health M&A multiples higher or lower than in previous years?
That requires a consistent, current transaction dataset with comparable deal definitions. This article does not claim to provide one.
How do I calculate my practice’s adjusted EBITDA?
Begin with reported earnings and evaluate each proposed adjustment against supporting records and the costs a buyer would continue to incur. The final figure is negotiated, not self-declared.
Do I need to know my EBITDA to get a valuation?
No. A valuation can begin with financial statements, tax records, payroll, billing reports, and owner interviews. The analysis should build and document normalized earnings.
Why might larger practices receive different offers than smaller ones?
Larger practices may attract different buyers or financing, but size does not guarantee a higher multiple. Leadership depth, concentration, earnings quality, and risk remain central.
Are ABA therapy practices a strong sell in 2026?
That cannot be answered categorically. Buyer interest depends on the specific practice and current, verifiable conditions when it goes to market.
What’s the difference between enterprise value and what I’ll take home from a sale?
Enterprise value is a headline value for the operating business under stated assumptions. Seller proceeds depend on debt, cash, working capital, taxes, fees, escrows, contingent payments, rollover equity, and other transaction terms.